Allergic reaction to mecasermin

Annals of Allergy, Asthma and Immunology

Volumn 103, Issue 1, 2009, Pages 82-83

  Metz, Kelly Allred ^a   Assa'Ad, Amal ^a   Lierl, Michelle B ^a   Backeljauw, Philippe ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DIPHENHYDRAMINE; GROWTH HORMONE; METHYLPREDNISOLONE; RANITIDINE; RECOMBINANT SOMATOMEDIN C; SALBUTAMOL;

CASE REPORT; CHILD; DRUG DOSE TITRATION; DRUG HYPERSENSITIVITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; INJECTION SITE REACTION; LETTER; MALE; PHYSICAL EXAMINATION; PRICK TEST; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE; SKIN TEST; URTICARIA;

EID: 67650351077     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60150-0     Document Type: Letter

References (11)

1. Guevara-Aguirre J, Vasconez O, Martinez V, et al. A randomized, double blind, placebo controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab. 1995;80:1393-1398.
2. Backeljauw PF, Underwood LE. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome: a clinical research center study. J Clin Endocrinol Metab. 1996;81:3312-3317. (Pubitemid 26296208)
3. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Wilton P; The Working Group on Growth Hormone Insensitivity Syndromes. Long-term treatment of growth hormone insensitivity syndrome with IGF-I: results of the European Multicentre Study. Horm Res. 1999;51:128-134.
4. Laron Z, Klinger B. Comparison of the growth-promoting effects of insulin-like growth factor I and growth hormone in the early years of life. Acta Paediatr. 2000;89:38-41. (Pubitemid 30060627)
5. Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE; GH Insensitivity Syndrome Collaborative Group. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab. 2007;92:813-814. (Pubitemid 46465661)
6. Torjusen E, Calderon J, Rivkees SA. Anaphylactic reaction to recombinant insulin-like growth factor-I. J Pediatr Endocrinol Metabolism. 2008;21:381-384. (Pubitemid 351802731)
7. Recombinant Human Insulin-Like Growth Factor-1 Investigator's Brochure. Brisbane, CA: Tercica Inc; March 2007.
8. Adamo ML, Neuenschwander S, LeRoith D, Roberts CT Jr. Structure, expression, and regulation of the IGF-1 gene. Adv Exp Med Biol. 1993;343:1. (Pubitemid 24059271)
9. Heinzerling L, Raile K, Rochlitz H, Zuberbier T, Worm M. Insulin allergy: clinical manifestations and management strategies. Allergy. 2008;63:148-155.
10. Winocour PH, Haeney M. Persistent local insulin allergy in a diabetic with chronic lymphatic leukaemia. Postgrad Med J. 1986;62:865-868. (Pubitemid 16012290)
11. Kuntze J, Franklin S, Frane J, Blethen S. Safety of Increlex Treatment in the IGFD Registry. Poster P2-564 presented at the 90th Endocrine Society Meeting; San Francisco, California; June 2008.